STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Clinical trials for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) explained in plain language.
Never miss a new study
Get alerted when new STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) trials appear
Sign up with your email to follow new studies for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental stem cell therapy tested for dangerous transplant complication
Disease control Recruiting nowThis early-stage trial is testing a new stem cell treatment for patients with a severe complication called graft-versus-host disease (GVHD) that doesn't respond to standard steroid treatment. The study will give 12 patients lab-grown stem cells derived from human stem cells to se…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Last-Chance drug access for serious illnesses
Disease control AVAILABLEThis program provides access to the drug ruxolitinib for patients with serious conditions like certain blood cancers and severe graft-versus-host disease. It is for people who have no other treatment options and cannot join a standard clinical trial. The program allows doctors to…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC